STING1 and cancer: Dying or damaged cancer cell–derived DNA can act as a damage-associated molecular pattern sensed by cytosolic cGAS-STING machinery in tumor-associated CD8α+ dendritic cells (DCs), leading to the production of type I IFNs (Deng et al., 2014; Woo et al., 2014).